undamentalytics Newsletter
Sign in

Nexgel, Inc. cash flow statement

In fiscal 2025, Nexgel, Inc.'s operations generated −$1.3m of cash; it spent $68,000 on capital projects, leaving free cash flow of −$1.4m.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash from operations−2−2−2−3−3−3−4−1−3
Depreciation and amortisation000000001
Stock-based pay000000011
Capital spending—00001000
Free cash flow—−2−2−3−3−4−4−1−3
Free cash flow after stock pay—−2−2−3−3−4−5−2−4
Shares issued01113—————

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: NXGL vs SINTNXGL vs OSURMDXG vs NXGL

More: Health Care Supplies stocks compared, Health Care sector, rankings of US companies

Figures from Nexgel, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Nexgel, Inc.